Oncotelic Therapeutics, Inc. Deferred Tax Liabilities, Investments
Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Liabilities, Investments of $111.55 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilitiesInvestments · last filed 2026-04-15
- 2025-12-31: Deferred Tax Liabilities, Investments $111.55M.
| Period end | Deferred Tax Liabilities, Investments |
|---|---|
| 2025-12-31 | $111.55M 10-K · filed 2026-04-15 |